RecruitingNot ApplicableNCT06054633

L-arginine for Knee Osteoarthritis Patients

Efficacy and Safety of Oral L-Arginine for Pain Relief in Knee Osteoarthritis: a Randomized, Double-Blind, Placebo-Controlled Trial

Sponsor

Xiangya Hospital of Central South University

Enrollment

340 participants

Start Date

Mar 20, 2024

Study Type

INTERVENTIONAL

Conditions

Osteoarthritis, Knee

Summary

This study will examine the pain-relief efficacy and safety of L-arginine in knee OA patients.

Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying L-arginine tablet and Placebo tablet for people with osteoarthritis, knee. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.